Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 6,000 shares at $198.01 ($1.2M) on 2021-04-13, disclosed to the SEC on 2021-04-15.
Open-market sale of $1.2M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.01 | 3,500 | $693K | 58.1% |
| 2 | $200.00 | 2,500 | $500K | 41.9% |
| Total | $198.84 avg | 6,000 | $1.2M | 100% |
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |